Evidence brief · July 2026

Tirzepatide dosing guide: 2.5 mg to 15 mg

Tirzepatide is titrated from 2.5 mg to 15 mg over about five months. Here's the standard schedule, what each dose does, and how to handle missed doses.

EC
Written & reviewed
Eduard Cristea · Clinically reviewed by Dr. A. Goher, MD
Updated July 6, 2026
Quick answer. The standard Zepbound schedule increases the weekly dose by 2.5 mg every four weeks: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg. The starter dose builds tolerance. Many people get strong results before reaching 15 mg. Never double up after a missed dose.

The escalation schedule

Tirzepatide's ladder has six steps, each held four weeks, reaching the 15 mg maximum at about week 21. The 2.5 mg starter dose exists to build GI tolerance and isn't intended to drive weight loss.

Because efficacy rises with dose, the titration is also a gradual dialing-up of effect — appetite suppression typically strengthens noticeably from 7.5–10 mg upward.

Not everyone climbs the full ladder. Clinicians frequently hold patients at 10 or 12.5 mg when results are strong and side effects acceptable, since the incremental benefit of the top dose varies by person and higher doses cost more on tiered plans.

Standard tirzepatide titration (2.5 → 15 mg).

What each dose does

The lower doses (2.5–5 mg) build tolerance; the middle doses (7.5–10 mg) deliver strong weight loss for many; and the top doses (12.5–15 mg) maximize the effect for those who need and tolerate them.

SURMOUNT-1 quantified this: ~15.0% loss at 5 mg, ~19.5% at 10 mg, and ~20.9% at 15 mg — so even mid-ladder doses produce substantial results.

This dose-dependent efficacy is why the conversation with your clinician about where to stop matters. If 10 mg gets you to your goal with easy tolerability, pushing to 15 mg may add cost and side effects for a modest additional benefit — a genuinely individual trade-off.

DoseWeeksRoleApprox. loss (SURMOUNT-1)
2.5 mg1–4Build tolerance
5 mg5–8First therapeutic dose~15.0%
7.5–10 mg9–16Strong effect~19.5% (10 mg)
12.5–15 mg17+Maximum effect~20.9% (15 mg)

Missed doses and practical tips

If you miss a dose and the next is 4+ days away, take it when you remember; if under 4 days, skip it and resume your schedule. Never take two doses close together. After an extended gap, your clinician may restart you at a lower dose to re-tolerate.

Inject any day of the week, with or without food; rotate injection sites; and keep the medication stored per label instructions.

Consistency beats perfection. Picking a fixed weekly day you'll remember — and setting a reminder — does more for your results than optimizing the exact hour. If life disrupts the schedule, follow the missed-dose rules rather than trying to improvise a catch-up.

Editor's Pick. For a transparent flat-rate program with visits, labs, and shipping bundled, NexLife is our July 2026 pick — $145/mo semaglutide, $186/mo tirzepatide. Not the cheapest sticker (Embody lists lower), but the lowest predictable all-in cost. Check NexLife →

The bottom line

Tirzepatide's 2.5-to-15 mg ladder is designed to make a powerful drug tolerable. The starter dose builds tolerance, mid-ladder doses already deliver strong results, and the top doses maximize effect for those who need them — so 15 mg is a ceiling, not a mandatory destination.

Work with your clinician on where to stop. If a mid-ladder dose gets you to your goal comfortably, that may be the smart place to hold — both for side effects and for cost on tiered plans. A flat-rate program removes the price penalty for climbing to the dose that works best.

The consistent lesson from the evidence is that tirzepatide rewards persistence and support. Weight and metabolic benefits track with reaching an effective dose and holding it, paired with protein and strength training; they fade when treatment stops. So when comparing options, weigh not just the headline price but whether the program's cost and clinical support let you stay the course.

How we verify pricing & evidence

Pricing on this page is drawn from the RangeYourself Independent GLP-1 Telehealth Price Index, human-verified against each provider's live pricing page between July 1 and July 3, 2026, and used under CC-BY-4.0 with attribution. Clinical figures come from the published pivotal trials — the STEP program for semaglutide and the SURMOUNT program for tirzepatide — plus peer-reviewed cardiovascular and body-composition studies. Treat every price as verified-as-of-July-2026 and reconfirm with the provider before acting; compounded GLP-1 medications are not FDA-approved and differ from the brand products the trials studied.

Frequently asked questions

How long until I reach the full tirzepatide dose?

About 21 weeks on the standard schedule, reaching 15 mg after five 4-week steps from the 2.5 mg start. Many people hold at an effective lower dose.

What if I miss a tirzepatide dose?

If your next dose is 4+ days away, take the missed dose when you remember; if under 4 days, skip it. Never double up. After an extended gap, your clinician may restart lower.

Do I need to reach 15 mg?

No. Mid-ladder doses like 10 mg already produce strong results (~19.5% in SURMOUNT-1). Clinicians hold patients at the dose that balances results, side effects, and cost.

Does injection timing matter?

No — inject any day, with or without food. Pick a consistent weekly schedule and rotate injection sites.

Key takeaways

How we rank. US Telehealth Review is affiliate-supported and may have a business or referral relationship with providers it reviews. Rankings are editorial; providers cannot pay for placement. Compounded GLP-1 medications are not FDA-approved. Details checked July 2026 — verify with each provider. Not medical advice.